Table 3 Effect of SE treatment on liver function tests, kidney function tests and lipid profile parameters

ALT (U/L)

16.0 ± 2.1^a

15.7 ± 1.6^a

91.0 ± 3.5^b

31.2 ± 2.1^c

28.3 ± 1.8^d

AST (U/L)

63.2 ± 2.4^a

65.3 ± 4.2^a

226.9 ± 4.6^b

73.4 ± 6.1^c

74.7 ± 7.7^c

ALP (U/L)

67.2 ± 2.1^a

71.6 ± 4.8^a

171.0 ± 4.2^b

113.6 ± 5.2^c

103.8 ± 7.2^d

TP (g/dl)

54.4 ± 4.4^a

53.6 ± 3.6^a

5.08 ± 0.8^b

31.4 ± 1.6^c

42.9 ± 1.4^d

Albumin (g/dl)

36.1 ± 0.68^a

35.8 ± 0.71^a

5.8 ± 1.60^b

14.2 ± 0.66^c

21.4 ± 2.49^d

Creatinine (mg/dl)

0.38 ± 0.05^a

0.37 ± 0.02^a

1.83 ± 0.08^b

1.04 ± 0.04^c

0.73 ± 0.04^d

Urea (mg/dl)

22.5 ± 1.7^a

23.3 ± 1.4^a

98.9 ± 3.5^b

71.6 ± 6.6^c

40.2 ± 3.3^d

LDL (mg/dl)

52 ± 0.7^a

31 ± 0.3^b

832 ± 1.6^c

355 ± 1.9^d

249 ± 1.1^e

HDL (mg/dl)

40.6 ± 1.8^a

39.4 ± 1.8^a

13.8 ± 2.3^b

27.5 ± 2.7^c

33.8 ± 2.3^d

TG (mg/dl)

113 ± 6.1^a

115 ± 9.4^a

412 ± 5.8^b

262 ± 9.7^c

216 ± 8.9^d